RIF
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RIF, covering 2019-11-29 to 2025-07-20. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of RIF Combined With Anlotinib in the Treatment of Patients With Advanced Recurrent Platinum-Resistant Ovarian Cancer: A Prospective, Multicenter Clinical Study [Phase 4]